Variant report
Variant | nsv963510 |
---|---|
Chromosome Location | chr3:20986272-21001315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:20992240..20993903-chr3:21005773..21007953,2 | K562 | blood: | |
2 | chr3:20884787..20886669-chr3:20993293..20995378,2 | K562 | blood: | |
3 | chr3:20982315..20984079-chr3:20994632..20996154,2 | K562 | blood: | |
4 | chr3:20980465..20983126-chr3:20989723..20991835,2 | K562 | blood: | |
5 | chr3:20994011..20995971-chr3:21005027..21007976,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KAT2B-9 | chr3:20995660-20995726 | NONHSAT088631 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558519904 | chr3:20995678-20995679 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs573273597 | chr3:20995693-20995694 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs540664359 | chr3:20995720-20995721 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs115746461 | chr3:20999037-20999038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556401755 | chr3:20999039-20999040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577963156 | chr3:20999061-20999062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545309636 | chr3:20999077-20999078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554117536 | chr3:20999093-20999094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73819246 | chr3:20999150-20999151 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs542364549 | chr3:20999154-20999155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140896048 | chr3:20999206-20999207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560695533 | chr3:20999207-20999208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573803638 | chr3:20999259-20999260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149760229 | chr3:20999317-20999318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565142637 | chr3:20999331-20999332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188314207 | chr3:20999365-20999366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562107935 | chr3:20999370-20999371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73044910 | chr3:20999399-20999400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528019364 | chr3:20999420-20999421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201462247 | chr3:20999446-20999447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180872357 | chr3:20999519-20999520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547685779 | chr3:20999526-20999527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373725785 | chr3:20999528-20999529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530136510 | chr3:20999566-20999567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185282854 | chr3:20999600-20999601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572608629 | chr3:20999609-20999610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570122205 | chr3:20999644-20999645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567578167 | chr3:20999747-20999748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190192279 | chr3:20999759-20999760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs882238 | chr3:20999820-20999821 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs538538273 | chr3:20999898-20999899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183542477 | chr3:20999903-20999904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs882237 | chr3:20999930-20999931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78857365 | chr3:20999957-20999958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75660814 | chr3:20999965-20999966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575687426 | chr3:21000008-21000009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140551197 | chr3:21000043-21000044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs882239 | chr3:21000069-21000070 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs577401820 | chr3:21000124-21000125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17812823 | chr3:21000125-21000126 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs571443069 | chr3:21000447-21000448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77094418 | chr3:21000469-21000470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141340562 | chr3:21000489-21000490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565926577 | chr3:21000495-21000496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548284548 | chr3:21000504-21000505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536161472 | chr3:21000535-21000536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554118591 | chr3:21000627-21000628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575650264 | chr3:21000639-21000640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143349519 | chr3:21000651-21000652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192207609 | chr3:21000678-21000679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20999000-20999800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr3:20999000-21000000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr3:20999000-21000000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr3:20999000-21000000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr3:20999600-21000000 | Enhancers | Fetal Lung | lung |
6 | chr3:20999600-21000200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr3:21000400-21000800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr3:21000800-21015600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |